Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-26

Clinical Trial Update: A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety and preliminary activity of SHR-4506 injections in adults with malignant tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR-4506

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Malignant Tumors of Adults | Phase 1 | Status: RECRUITING